Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest Simon J. Hall Stories

2014-01-30 23:02:32

Mount Sinai experts share tips for prostate cancer prevention and new advancements in treatment and detection. New York, NY (PRWEB) January 30, 2014 Prostate cancer is the second leading cause of cancer death in American men. One in six men will be diagnosed with prostate cancer and 230,000 new cases are diagnosed annually. Overall, the five-year survival rate is 100 percent for men with the disease confined to the prostate or nearby tissue. Expert Available for Interview: Ash Tewari,...

2013-10-17 12:29:35

Ocean Medical Center is first hospital in Monmouth and Ocean Counties to offer Xofigo treatment. BRICK, N.J., Oct. 17, 2013 /PRNewswire-USNewswire/ -- Men who have been diagnosed with advanced prostate cancer now have a new treatment option at Ocean Medical Center. Recently approved by the FDA, Xofigo is an intravenous (IV) injection of a radioactive material that treats metastatic prostate cancer resistant to medical or surgical treatments. If prostate cancer grows outside of the...

2013-07-11 16:24:41

BRONX, N.Y., July 11, 2013 /PRNewswire-USNewswire/ -- Researchers at Albert Einstein College of Medicine of Yeshiva University have found that nerves play a critical role in both the development and spread of prostate tumors. Their findings, using both a mouse model and human prostate tissue, may lead to new ways to predict the aggressiveness of prostate cancer and to novel therapies for preventing and treating the disease. The study published online today in the July 12 edition of...

2013-06-02 23:15:07

Mount Sinai researchers to present landmark studies at American Society of Clinical Oncology meeting. New York, NY (PRWEB) June 01, 2013 Icahn School of Medicine at Mount Sinai researchers will present several landmark studies at the 2013 American Society of Clinical Oncology (ASCO) meeting May 31-June 4, 2013 in Chicago, including data on the likelihood of spousal human papillomavirus (HPV) oral infection, new gene signatures in melanoma, and issues with high readmission rates after cancer...

2013-05-09 23:21:42

℠Cureatr´ App Developed by Mount Sinai Hospital Resident Dr. Joseph Mayer New York (PRWEB) May 09, 2013 The Mount Sinai Medical Center has adopted an enterprise-grade mobile care-coordination mobile app called Cureatr, which was designed by a resident at the Mount Sinai Hospital, Joseph Mayer, MD. Mount Sinai has signed a multi-year contract to roll out the app to Mount Sinai clinicians. “Mount Sinai is the first major academic medical center to adopt Cureatr,” said...

2013-01-23 16:24:13

CLEVELAND, Jan. 23, 2013 /PRNewswire/ -- A team of researchers led by Goutham Narla, MD, PhD, at Case Western Reserve University School of Medicine and University Hospitals Case Medical Center, and collaborators at the Mount Sinai School of Medicine and Erasmus Medical Center, have discovered a gene variant that drives the spread of breast cancer. Published in Science Translational Medicine, the study lays the early foundation for predicting which breast cancer patients may develop more...